The iCMLf has compiled for you expert talks, frequently asked questions, statements, expert opinions and interesting cases on COVID-19 and CML from reliable sources.

1. Frequently asked questions (FAQs) on COVID-19 and CML

• FAQs on COVID-19 and CML on the ASH COVID-19 Resources
  (Last updated September 28, 2021)
  Input from Michael Mauro (USA), Brian Druker (USA), Jerald Radich (USA), Jorge Cortes (USA), Tim H. Brümmendorf (Germany), Guiseppe Saglio (Italy), Timothy Hughes (Australia) and Delphine Rea (France)
  

  

• FAQs: CML, TKI treatment and COVID-19 disease on behalf of the ELN/EHA-SWG for CML
  (Last updated March 29, 2020)
  Input from Dr Delphine Rea, Saint-Louis University Hospital, Paris, France and Prof Rudiger Hehlmann
  
  

2. iCMLf Conversations on COVID-19 and CML

The iCMLf hosted conversations on CML and COVID-19 with renowned experts in CML that addressed key questions on how to manage patients with CML during the COVID-19 pandemic. You can view recordings of these conversations here. The content of the presenations express the individual opinions of the respective experts.

• CML in the era of COVID-19
  Professor Jorge Cortes, Augusta (USA) (June 2020)
• Management recommendations for patients with CML during the pandemic
  Professor Gianantonio Rosti, Bologna (Italy) (July 2020)
• Management of patients with CML and COVID-19
  Dr Delphine Réa, Paris (France) (July 2020)
• What do we know about COVID-19 so far from the real-world?
  Professor Hemant Malhotra, Jaipur (India) and Dr Katia Pagnano, Sao Paulo (Brazil)

View recordings of the iCMLf Conversations on COVID-19 and CML here

You can also view recordings of iCMLf Conversations on COVID-19 and CML in Non-English languages

• Update on CML and COVID-19 management (in Spanish)
  Dr Carolina Pavlovsky / Dr. Beatriz Moiraghi
  
  
• Update on CML and COVID-19 management (in Portuguese)
  Dr Katia Pagnano / Dr Carla Boquimpani / Dr Ana Carolina Toreli
  
  
• Update on CML and COVID-19 management (in Russian)
  Dr Elza Lomaia (Russian Federation) (May 2022)
  
  
• Update on CML and COVID-19 management (in French)
  Dr Delphine Réa, Paris (France) (April 2022)
  
  

3. Clinical Case discussion related to COVID-19

Physicians can post specific patient cases related to COVID-19 and CML for advice and discussion on the iCMLf Clinical Case Discussion Forum.

Discussions related to COVID-19 and CML can be found here:

• COVID vaccine for CML patients?
• IFN treatment during the COVID-19 pandemic
• Should I stop or change TKI therapy given the current Coronavirus outbreak?
  
  

4. Expert opinions on COVID-19 and CML

The iCMLf is sharing a series of valuable expert opinions and webinars from other resources that address questions on how to best manage patients with COVID-19 and CML.

• ESMO-EHA Interdisciplinary Expert Consensus: Managing hematological cancer patients during the COVID-19 pandemic (Buske et al. - open access publication)
• Expert opinion Professor Jeff Lipton: Interferon and CML during the COVID-19 pandemic
• PatientPower Interview with Professor Michael Mauro: Expert takes questions from patients and care partners on managing CML during the pandemic
  
  

5. Advice for people with CML and COVID -19

The iCMLf is sharing an expert statements specifically for chronic phase CML patients on the novel coronavirus and the COVID-19 disease.

• COVID-19 (coronavirus) advice for patients with CML receiving TKI therapy
  NCRI (National Cancer Research Center, UK) (Last updated August 2021)
• Information for Chronic Phase Chronic Myeloid Leukemia Patients
  Michael Deininger (USA), François Guilhot (France), Jeroen Janssen (Netherlands), Tim Hughes (Australia), Jeffrey Lipton (Canada), Franck Nicolini (France), Jerry Radich (USA), Delphine Rea (France), Giuseppe Saglio (Italy), Susanne Saussele (Germany), Rick Silver (USA), Juan-Luis Steegmann (Spain)
  (Last updated March 8, 2020)